HPR157 Repurposed Drugs Launched Under the AMNOG in Germany: Effects on Benefit Assessment and Price Development
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1286
https://www.valueinhealthjournal.com/article/S1098-3015(22)03491-X/fulltext
Title :
HPR157 Repurposed Drugs Launched Under the AMNOG in Germany: Effects on Benefit Assessment and Price Development
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03491-X&doi=10.1016/j.jval.2022.09.1286
First page :
Section Title :
Open access? :
No
Section Order :
10836